% | $
Quotes you view appear here for quick access.

Agenus Inc. Message Board

  • dinepat203 dinepat203 Oct 3, 2013 10:39 AM Flag

    $15 with FDA meeting coming soon!!!!!!!!!

    Agenus plans to discuss a late-stage trial with the U.S. Food and Drug Administration, based on the trial data.
    A preliminary analysis of the study in May had showed that the vaccine had a 146 percent increase in progression-free survival when compared with the standard-of-care.
    "We are impressed by the data and look forward to feedback from the FDA regarding next steps," Roth Capital Partners analyst Joseph Pantginis wrote in a note, raising the price target on the stock to $15.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
5.81-0.06(-1.02%)10:11 AMEDT